This Super-Tall Robotic Arm Is Made of Helium Balloons
What’s bright silver, weighs next to nothing, and can reach up to the fifth floor? No, not an aluminum ladder. This inflatable robotic arm.
While most robot arms are trying to develop brains, this one’s gone on a strict diet. Unlike the robotic arms you might find in a factory, this device, developed by the Suzumori Endo Laboratory at the Tokyo Institute of Technology and discovered by IEEE Spectrum, uses a series of helium-filled balloons to form its arm. The use of balloons means that the entire 20-meter-long structure weighs just 1.2 kilograms—light enough for simple pneumatic artificial muscles to be used to articulate its joints from the ground.

There are some very evident drawbacks to the so-called Giacometti Arm—presumably named after artist Alberto Giacometti, who is famous for his slender, spindly sculptures depicting the human form. Its lightweight nature means that it would be easily buffeted by winds, for instance. It clearly can’t carry a great deal, either. And it’s only as resilient as its balloons.
But the researchers behind it suggest that because it’s so light and packable, it could theoretically be used for search and inspection tasks. It’s certainly plausible that it could be used in situations where it might be difficult to transport a heavyweight device, say, or where the use of a drone isn’t an option for battery-life reasons.
(Read more: “Japanese Robotics Giant Gives Its Arms Some Brains,” “Google Builds a Robotic Hive-Mind Kindergarten”)
Keep Reading
Most Popular

Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.